{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:02:40Z","timestamp":1791583360683,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Sinocare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s13300-025-01832-6","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:28:11Z","timestamp":1767029291000},"page":"287-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of a New Continuous Glucose Monitoring System in German Adults Living with Diabetes"],"prefix":"10.1007","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct05806554","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Nina","family":"Jendrike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fckr\u00fc","family":"\u00d6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfeng","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Flacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Eichenlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Freckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1832_CR1","volume-title":"POCT05\u2014performance metrics for continuous interstitial glucose monitoring","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. POCT05\u2014performance metrics for continuous interstitial glucose monitoring. 2nd ed. Wayne: Clinical and Laboratory Standards Institute; 2020.","edition":"2"},{"key":"1832_CR2","unstructured":"United Stated Code of Federal Regulations. Integrated continuous glucose monitoring system. https:\/\/www.ecfr.gov\/current\/title-21\/section-862.1355. Accessed 19 Feb 2025."},{"issue":"3","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/dia.2022.0331","volume":"25","author":"P Stephan","year":"2023","unstructured":"Stephan P, Eichenlaub M, Waldenmaier D, et al. A statistical approach for assessing the compliance of integrated continuous glucose monitoring systems with Food and Drug Administration accuracy requirements. Diabetes Technol Ther. 2023;25(3):212\u20136. https:\/\/doi.org\/10.1089\/dia.2022.0331.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/19322968221134639","volume":"18","author":"M Eichenlaub","year":"2024","unstructured":"Eichenlaub M, Stephan P, Waldenmaier D, et al. Continuous glucose deviation interval and variability analysis (CG-DIVA): a novel approach for the statistical accuracy assessment of continuous glucose monitoring systems. J Diabetes Sci Technol. 2024;18(4):857\u201365. https:\/\/doi.org\/10.1177\/19322968221134639.","journal-title":"J Diabetes Sci Technol"},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.sjpain.2016.06.012","volume":"13","author":"GZ Heller","year":"2016","unstructured":"Heller GZ, Manuguerra M, Chow R. How to analyze the visual analogue scale: myths, truths and clinical relevance. Scand J Pain. 2016;13:67\u201375. https:\/\/doi.org\/10.1016\/j.sjpain.2016.06.012.","journal-title":"Scand J Pain"},{"key":"1832_CR6","doi-asserted-by":"publisher","DOI":"10.2337\/db24-987-P","author":"L Ji","year":"2024","unstructured":"Ji L, Flacke F, Gao F, et al. 987-P: iCan CGM system\u2014performance evaluation of a new CGM system with an innovative sensor technology. Diabetes. 2024. https:\/\/doi.org\/10.2337\/db24-987-P.","journal-title":"Diabetes"},{"issue":"6","key":"1832_CR7","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1177\/19322968231190941","volume":"17","author":"G Freckmann","year":"2023","unstructured":"Freckmann G, Eichenlaub M, Waldenmaier D, et al. Clinical performance evaluation of continuous glucose monitoring systems: a scoping review and recommendations for reporting. J Diabetes Sci Technol. 2023;17(6):1506\u201326. https:\/\/doi.org\/10.1177\/19322968231190941.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1177\/19322968241267774","volume":"18","author":"JK Mader","year":"2024","unstructured":"Mader JK, Waldenmaier D, Mueller-Hoffmann W, et al. Performance of a novel continuous glucose monitoring device in people with diabetes. J Diabetes Sci Technol. 2024;18(5):1044\u201351. https:\/\/doi.org\/10.1177\/19322968241267774.","journal-title":"J Diabetes Sci Technol"},{"key":"1832_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251351318","author":"N Jendrike","year":"2025","unstructured":"Jendrike N, Eichenlaub M, Link M, et al. Comparative performance analysis of manual and updated optional calibration algorithms for the CareSens Air CGM System. J Diabetes Sci Technol. 2025. https:\/\/doi.org\/10.1177\/19322968251351318.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1177\/19322968231156572","volume":"18","author":"AM Markov","year":"2024","unstructured":"Markov AM, Krutilova P, Cedeno AE, McGill JB, McKee AM. Interruption of continuous glucose monitoring: frequency and adverse consequences. J Diabetes Sci Technol. 2024;18(5):1096\u2013101. https:\/\/doi.org\/10.1177\/19322968231156572.","journal-title":"J Diabetes Sci Technol"},{"key":"1832_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241250357","author":"DC Klonoff","year":"2024","unstructured":"Klonoff DC, Gabbay M, Moon SJ, Wilmot EG. Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring. J Diabetes Sci Technol. 2024. https:\/\/doi.org\/10.1177\/19322968241250357.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/dom.16153","volume":"27","author":"C Mathieu","year":"2025","unstructured":"Mathieu C, Irace C, Wilmot EG, et al. Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-\u2018eCGM\u2019 compliance status. Diabetes Obes Metab. 2025;27(3):1025\u201331. https:\/\/doi.org\/10.1111\/dom.16153.","journal-title":"Diabetes Obes Metab"},{"key":"1832_CR13","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2025.0139","author":"SK Garg","year":"2025","unstructured":"Garg SK, Bailey TS, Castorino K, et al. Accuracy of the 15.5-day G7 iCGM in adults with diabetes. Diabetes Technol Ther. 2025. https:\/\/doi.org\/10.1089\/dia.2025.0139.","journal-title":"Diabetes Technol Ther"},{"key":"1832_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251329364","author":"S Alva","year":"2025","unstructured":"Alva S, Bhargava A, Bode B, et al. Accuracy of a 15-day factory-calibrated continuous glucose monitoring system with improved sensor design. J Diabetes Sci Technol. 2025. https:\/\/doi.org\/10.1177\/19322968251329364.","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01832-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:03:25Z","timestamp":1771268605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01832-6","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nina Jendrike, Manuela Link, S\u00fckr\u00fc \u00d6ter, and Manuel Eichenlaub are employees of the Institut f\u00fcr Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universit\u00e4t Ulm (IfDT), which carries out clinical studies, e.g., with medical devices for diabetes therapy on its own initiative and on behalf of various companies. Guido Freckmann is the general manager and medical director of IfDT. Guido Freckmann\/IfDT have received research support, speakers\u2019 honoraria or consulting fees in the last 3\u00a0years from Abbott, Ascensia, Bionime, Boydsense, Dexcom, Insulet, I-Sens, Lilly, Menarini, Novo Nordisk, Perfood, Pharmasens, Roche, Sinocare, Terumo, Vertex, Ypsomed. Leon Shi and Poul Strange are employees of Integrated Medical Development, which plans and executes clinical studies and is a contractor of Sinocare. Frank Flacke is employee and owner of Flacke Consulting GmbH providing strategy advise, medical affairs and clinical affairs services and is or was within the past 3\u00a0years a contractor of Sinocare, BOYDSense, embecta, Sanofi, Glucoset. Jiangfeng Fei, Jiyun Zheng, Fei Gao, Ao Gao, and Siting Zhu are all employees of Sinocare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Study was registered under ClinicalTrials.gov (ID: NCT05806554). Ethical approval for this study was obtained by the Ethics Committee of the State Medical Association of Baden-W\u00fcrttemberg (Ethik-Kommission der Landes\u00e4rztekammer Baden-W\u00fcrttemberg, Stuttgart, Germany). The study was performed in accordance to the declaration of Helsinki. All study participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}